Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET.
You’ll need to join the group to register, membership is free for AAPS members.
This work builds off Aimee’s AAPS PharmSci360 poster session on in silico approaches for handling unnatural amino acids(AA) in immunogenic risk assessment. As protein engineering techniques become more sophisticated Unnatural AA sequences are becoming more and more common, and present unique challenges for assessing immunogenicity.
Aimee is an engaging presenter, expect her to cover the basics of in silico immunogenicity prediction for protein and peptide therapeutics, before jumping into the EpiVax approach for handling Unnatural Amino Acids. There will be time for questions and discussions at the end.
Not familiar with AAPS BPABC? Learn how to join here. AAPS Communities are free for AAPS members, and are a great way to connect with researchers in the same area of study.